SS
TAK icon

Simplicity Solutions’s Takeda Pharmaceutical TAK Stock Holding History

Simplicity Solutions’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$3.45M Buy
241,462
+27,947
+13% +$397K 0.09% 197
2023
Q3 		$3.3M Buy
213,515
+955
+0.4% +$14.8K 0.11% 180
2023
Q2 		$3.34M Buy
212,560
+16,655
+9% +$273K 0.09% 206
2023
Q1 		$3.23M Sell
195,905
-2,456
-1% -$39.1K 0.08% 217
2022
Q4 		$3.09M Buy
198,361
+6,726
+4% +$93.9K 0.42% 42
2022
Q3 		$2.49M Buy
191,635
+35,347
+23% +$491K 0.36% 54
2022
Q2 		$2.19M Buy
156,288
+37,169
+31% +$531K 0.28% 80
2022
Q1 		$1.71M Sell
119,119
-38,433
-24% -$564K 0.21% 105
2021
Q4 		$2.15M Buy
157,552
+103,010
+189% +$1.44M 0.24% 101
2021
Q3 		$893K Buy
54,542
+17,391
+47% +$292K 0.14% 166
2021
Q2 		$625K Buy
37,151
+10,596
+40% +$180K 0.12% 181
2021
Q1 		$485K Buy
26,555
+12,966
+95% +$233K 0.11% 204
2020
Q4 		$247K Buy
13,589
+2,056
+18% +$36.1K ﹤0.01% 841
2020
Q3 		$206K Sell
11,533
-1,675
-13% -$30.5K ﹤0.01% 823
2020
Q2 		$237K Sell
13,208
-3,468
-21% -$62.3K ﹤0.01% 792
2020
Q1 		$253K Sell
16,676
-3,347
-17% -$60.7K 0.01% 639
2019
Q4 		$395K Buy
20,023
+1,374
+7% +$26.3K 0.01% 604
2019
Q3 		$321K Buy
18,649
+114
+0.6% +$1.97K 0.01% 525
2019
Q2 		$328K Buy
+18,535
New +$337K 0.01% 466

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Simplicity Solutions's TAK Position: Q4 2023 in Review

Simplicity Solutions increased its Takeda Pharmaceutical (TAK) stake by 13% in Q4 2023, buying an estimated $397K and bringing the position to 241,462 shares worth $3.45M. The position accounts for 0.09% of the portfolio, ranked #197.

Simplicity Solutions first reported a position in TAK in Q2 2019 and has held it in 19 quarters since. 306 funds tracked by Wall St. Rank hold TAK as of Q4 2023.

  • Simplicity Solutions held 241,462 shares of Takeda Pharmaceutical worth $3.45M as of Q4 2023.
  • Simplicity Solutions bought 27,947 Takeda Pharmaceutical shares in Q4 2023, an estimated $397K.
  • Takeda Pharmaceutical made up 0.09% of Simplicity Solutions's portfolio in Q4 2023, its #197 holding.
  • Simplicity Solutions first reported a position in Takeda Pharmaceutical in Q2 2019 and has held it in 19 quarters since.
  • 306 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.